LY450139 (semagacestat)

semagacestat · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY450139 (semagacestat), covering 2014-09-25 to 2014-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Effect of LY450139 on the Long Term Progression of Alzheimer's Disease [Phase 3]